Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025 (Pritam Biswas/Reuters)

Techmeme ·

Isomorphic Labs, Google DeepMind's AI drug discovery spinoff, raised $2.1B led by Thrive, doubling down on its $600M March 2025 round and signaling serious investor confidence in AI-powered pharma.

Categories: Money & Moves

Excerpt

<p><a href="https://www.techmeme.com/260512/p29#a260512p29" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Pritam Biswas / <a href="http://www.reuters.com/">Reuters</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://www.reuters.com/legal/litigation/google-backed-isomorphic-raises-21-billion-scale-ai-driven-drug-discovery-2026-05-12/">Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025</a></b></span>&nbsp; &mdash;&nbsp; Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion &hellip; </p>